siRNA Screening Service for Infectious Disease Research

Small Interfering RNA (siRNA), a small molecule RNA, has a unique ability to specifically inhibit gene expression. Its mechanism of action involves precise binding with the target messenger RNA (mRNA), leading to mRNA degradation or blocking its translation process, effectively reducing the production of specific proteins. This precise regulatory capability makes siRNA a powerful tool for researching gene function and developing innovative therapies. In the field of infectious diseases research, Creative Biolabs offers professional support for this technology, helping clients explore and utilize the enormous potential of siRNA.

Fig.1 siRNA: mechanism of action, challenges, and therapeutic approaches.¹

Diverse Applications of siRNA in Infectious Disease Research

• Gene Function Research: By targeting specific genes, siRNA helps researchers understand the role of these genes in the life cycle of pathogens. This method can reveal host and pathogen genes that play a role in key steps such as pathogen replication, assembly, and release, providing an important tool for a deeper understanding of the mechanisms of infectious diseases.
• Therapy Development: The capability of siRNA lies in its ability to precisely target and inhibit the expression of pathogen genes, making it a strong candidate for developing anti-infection therapies. For example, siRNA therapies targeting HIV and hepatitis B virus have entered clinical trial stages. These therapies aim to reduce the quantity of pathogens, alleviating or preventing the progression of the disease.

Advanced High-Throughput siRNA Screening Services: Precision Selection of Optimal siRNA

Creative Biolabs provides high-throughput siRNA screening services to help researchers precisely select siRNAs that can most effectively inhibit the expression of specific genes, thereby achieving precise regulation of gene activity. This method is significant not only in gene research but also plays a key role in the drug development process. Our services feature:

• High-Efficiency Screening: Using advanced high-throughput screening technology, we can rapidly test thousands of siRNA sequences, significantly increasing screening efficiency and speed.
• Precise Targeting: Our screening services focus on selecting siRNAs with high specificity and targeting accuracy to ensure minimal impact on non-target genes.
• Data Analysis and Interpretation: We provide in-depth data analysis and interpretation services to help clients understand screening results, guiding subsequent experimental design and research directions.

Besides advanced screening services, Creative Biolabs also offers comprehensive follow-up optimization services, aimed at accelerating the development and success of client projects.

Professional Services to Optimize siRNA Targeting Effects

Although siRNA shows great therapeutic potential, its challenges in application, including effective delivery and targeting, cannot be ignored. Creative Biolabs provides a range of derivative services to overcome these challenges and optimize the targeting effects of siRNA.

• Novel siRNA Delivery System Development Services:

Our team is committed to working closely with clients to jointly design and optimize siRNA delivery systems, such as nanoparticles and liposomes. These advanced delivery systems ensure that siRNA can reach its target cells and tissues effectively and safely, thereby enhancing the effectiveness and specificity of therapies.

• siRNA Chemical Modification and Design Optimization Services:

Our expert team utilizes the latest technology and deep professional knowledge to offer clients customized improvement solutions for siRNA therapies. Through precise chemical modifications, we enhance the biological stability and intracellular persistence of siRNA, while optimizing its design to ensure more outstanding therapeutic effects and safety.

To explore your research potential and accelerate project progress, please contact us. We look forward to becoming your trusted partner.

Reference:

1. Alshaer, W.; et al. siRNA: mechanism of action, challenges, and therapeutic approaches. European Journal of Pharmacology. 2021, 905:174178.

• shRNA Screening
• miRNA Screening